Price $7.06 |
Market Cap
94.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.28
|
P/S
2.85
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
600
|
FCF
-0.1
|
|
Op. Margin
-4.40%
|
Net Margin
-2.90%
|
ROE
-1.30%
|
ROI
-1.40%
|
|
ROA
-1.00%
|
EPS Growth
-225.00%
|
Current Ratio
4.4
|
Debt/Equity
5.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Navidea Biopharmaceuticals Inc (NAVB) | $0.45 | - | - | 79.2M | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $6.80 | - | - | 76.3M | Strong Buy |
| Reliv International, Inc (RELV) | $7.98 | - | - | 12.1M | Strong Buy |
| Retractable Technologies, Inc. (RVP) | $1.09 | - | - | 31.7M | Strong Buy |
| MGC Diagnostics Corp (MGCD) | $8.21 | - | - | 37.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
